Pharmacogenetic biomarkers for companion and complementary diagnostics: challenges for clinical practice and regulation

MLA

Julia C. Stingl. “Pharmacogenetic Biomarkers for Companion and Complementary Diagnostics: Challenges for Clinical Practice and Regulation.” Expert Review of Precision Medicine and Drug Development, vol. 1, Sept. 2016, pp. 415–18. EBSCOhost, https://doi.org/10.1080/23808993.2016.1223526.

APA

Julia C. Stingl. (2016). Pharmacogenetic biomarkers for companion and complementary diagnostics: challenges for clinical practice and regulation. Expert Review of Precision Medicine and Drug Development, 1, 415–418. https://doi.org/10.1080/23808993.2016.1223526

Chicago

Julia C. Stingl. 2016. “Pharmacogenetic Biomarkers for Companion and Complementary Diagnostics: Challenges for Clinical Practice and Regulation.” Expert Review of Precision Medicine and Drug Development 1 (September): 415–18. doi:10.1080/23808993.2016.1223526.